Detalhe da pesquisa
1.
Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity.
Cell
; 169(6): 1130-1141.e11, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28552348
2.
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.
Cell
; 170(6): 1109-1119.e10, 2017 Sep 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28886381
3.
Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.
Cell
; 174(4): 1031-1032, 2018 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-30096300
4.
Three-Year Overall Survival with Tebentafusp in Metastatic Uveal Melanoma.
N Engl J Med
; 389(24): 2256-2266, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37870955
5.
Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma.
N Engl J Med
; 388(9): 813-823, 2023 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36856617
6.
Automated Quantitative CD8+ Tumor-Infiltrating Lymphocytes and Tumor Mutation Burden as Independent Biomarkers in Melanoma Patients Receiving Front-Line Anti-PD-1 Immunotherapy.
Oncologist
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38655867
7.
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.
N Engl J Med
; 385(13): 1196-1206, 2021 09 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34551229
8.
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
CA Cancer J Clin
; 67(6): 472-492, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-29028110
9.
Plain language summary of the CheckMate 76K study results: nivolumab given after stage 2B/2C melanoma is removed by surgery.
Future Oncol
; 20(15): 959-968, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38390818
10.
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
Lancet
; 399(10336): 1718-1729, 2022 04 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35367007
11.
Five-Year Analysis of Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma.
N Engl J Med
; 383(12): 1139-1148, 2020 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32877599
12.
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609.
Qual Life Res
; 32(1): 183-196, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36029412
13.
Pembrolizumab versus placebo as adjuvant therapy in resected stage IIB or IIC melanoma (KEYNOTE-716): distant metastasis-free survival results of a multicentre, double-blind, randomised, phase 3 trial.
Lancet Oncol
; 23(11): 1378-1388, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36265502
14.
Poorer survival outcomes in patients with multiple versus single primary melanoma.
Cancer
; 128(11): 2098-2106, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35319783
15.
Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males.
J Transl Med
; 20(1): 253, 2022 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35659704
16.
Co-expression of TNF receptors 1 and 2 on melanomas facilitates soluble TNF-induced resistance to MAPK pathway inhibitors.
J Transl Med
; 20(1): 331, 2022 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35879777
17.
Clinically Significant Risk Thresholds in the Management of Primary Cutaneous Melanoma: A Survey of Melanoma Experts.
Ann Surg Oncol
; 29(9): 5948-5956, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35583689
18.
Indoor tanning exposure in association with multiple primary melanoma.
Cancer
; 127(4): 560-568, 2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33170961
19.
Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial.
Lancet Oncol
; 21(3): 358-372, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32007138
20.
Prognosis and Management of BRAF V600E-Mutated Pregnancy-Associated Melanoma.
Oncologist
; 25(8): e1209-e1220, 2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32271498